You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 1, January 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Pediatric Forum
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Removing a Major Barrier to Universal Hepatitis B Immunization in Infants

Stephen P. Combs, MD; Emmanuel B. Walter, MD, MPH; Robert P. Drucker, MD; Dennis A. Clements, MD, PhD
Vaccine Unit Department of Pediatrics Duke University Medical Center 4020 Roxboro Rd Durham, NC 27705

Arch Pediatr Adolesc Med. 1996;150(1):112-114.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Fragmentation of health services remains a major barrier to achieving universal childhood vaccination. In a follow-up study to one performed 2 years ago, we1 demonstrate that one solution for achieving higher vaccination rates is accessibility to vaccines for children at the site at which routine health care is performed.

In accordance with the Advisory Committee on Immunization Practices recommendations for universal infant immunization with hepatitis B vaccine,2 Duke University Medical Center (DUMC), Durham, NC, began in February 1993 to offer hepatitis B vaccine to all infants prior to their being discharged from the hospital at birth. The recommendations of the Advisory Committee on Immunization Practices are that doses 2 and 3 of the hepatitis B vaccine be given at 1 to 2 and 6 to 18 months of age, respectively.

During the period of the original study at the DUMC pediatric practice, all children who were recipients of . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.